Bélgica - neerlandés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - natriumbicarbonaat 2,1 mg/ml; watervrij glucose 42,5 mg/ml - eq. watervrij glucose 38,6 g/l; magnesiumchloridehexahydraat 0,051 mg/ml; natriumchloride 5,67 mg/ml; natriumlactaat 1,12 mg/ml; calciumchloridedihydraat 0,71 g/l - oplossing voor peritoneale dialyse - watervrij glucose 42.5 mg/ml; magnesiumchloridehexahydraat 0.051 mg/ml; natriumlactaat 1.12 mg/ml; natriumbicarbonaat 2.1 mg/ml; natriumchloride 5.67 mg/ml; calciumchloridedihydraat - hypertonic solutions

Bélgica - neerlandés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - natriumbicarbonaat 2,1 mg/ml; magnesiumchloridehexahydraat 0,051 mg/ml; natriumchloride 5,38 mg/ml; natriumlactaat 1,68 mg/ml; glucosemonohydraat 15 mg/ml - eq. watervrij glucose 13,6 g/l; calciumchloridedihydraat 0,507 g/l - oplossing voor peritoneale dialyse - glucosemonohydraat 15 mg/ml; magnesiumchloridehexahydraat 0.051 mg/ml; natriumbicarbonaat 2.1 mg/ml; natriumchloride 5.38 mg/ml; natriumlactaat 1.68 mg/ml; calciumchloridedihydraat - hypertonic solutions

Bélgica - neerlandés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - natriumbicarbonaat 2,1 mg/ml; magnesiumchloridehexahydraat 0,051 mg/ml; natriumchloride 5,38 mg/ml; natriumlactaat 1,68 mg/ml; glucosemonohydraat 25 mg/ml - eq. watervrij glucose 22,7 g/l; calciumchloridedihydraat 0,507 g/l - oplossing voor peritoneale dialyse - glucosemonohydraat 25 mg/ml; magnesiumchloridehexahydraat 0.051 mg/ml; natriumbicarbonaat 2.1 mg/ml; natriumlactaat 1.68 mg/ml; natriumchloride 5.38 mg/ml; calciumchloridedihydraat - hypertonic solutions

Bélgica - neerlandés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxter sa-nv - natriumbicarbonaat 2,1 mg/ml; magnesiumchloridehexahydraat 0,051 mg/ml; natriumchloride 5,38 mg/ml; natriumlactaat 1,68 mg/ml; glucosemonohydraat 42,5 mg/ml - eq. watervrij glucose 38,6 g/l; calciumchloridedihydraat 0,507 g/l - oplossing voor peritoneale dialyse - glucosemonohydraat 42.5 mg/ml; magnesiumchloridehexahydraat 0.051 mg/ml; natriumchloride 5.38 mg/ml; natriumbicarbonaat 2.1 mg/ml; natriumlactaat 1.68 mg/ml; calciumchloridedihydraat - hypertonic solutions

Unión Europea - neerlandés - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kip - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Unión Europea - neerlandés - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influenza, human - vaccins - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Unión Europea - neerlandés - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals voor aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Unión Europea - neerlandés - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologicals voor aves - kip - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Unión Europea - neerlandés - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kip - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Unión Europea - neerlandés - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals voor aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).